Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). (Q36612231)
Jump to navigation
Jump to search
scientific article published on 8 August 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). |
scientific article published on 8 August 2006 |
Statements
1 reference
Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). (English)
1 reference
J Atzpodien
1 reference
H Kirchner
1 reference
U Rebmann
1 reference
M Soder
1 reference
U Gertenbach
1 reference
M Siebels
1 reference
J Roigas
1 reference
R Raschke
1 reference
S Salm
1 reference
B Schwindl
1 reference
S C Müller
1 reference
S Hauser
1 reference
C Leiber
1 reference
E Huland
1 reference
H Heinzer
1 reference
S Siemer
1 reference
B Metzner
1 reference
H Heynemann
1 reference
P Fornara
1 reference
M Reitz
1 reference
8 August 2006
1 reference
1 reference
463-469
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference